Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Poster Presentations

Female Reproduction

Previous section
Endocrine tumours and neoplasia
Table of contents
Next section
Growth hormone IGF axis - basic

ea0029p885 | Female Reproduction

The ovarian failure associated Y235 residue of human BMP15 gene is target of evolutionary positive selection

ea0029p886 | Female Reproduction

Coordinate regulation of heterogeneous nuclear ribonucleoprotein dynamics by steroid hormones in the human Fallopian tube and endometrium in vivo and in vitro

ea0029p887 | Female Reproduction

Role of the CRH receptors and brainstem noradrenergic nuclei in the gonadotropins secretion induced by acute stress at proestrus morning

ea0029p888 | Female Reproduction

An invdup (15) associated with premature ovarian insufficiency

ea0029p889 | Female Reproduction

Impact of thyroid status and thyroid autoimmunity on assisted reproduction technology outcome

ea0029p890 | Female Reproduction

The association of thyroid hormones with menstrually related mood disorder, sexual abuse histories and mood symptoms

ea0029p891 | Female Reproduction

Androgen profiling in adolescent females by liquid chromatography–tandem mass spectrometry

ea0029p892 | Female Reproduction

Expression of CRH/urocortin gene family in mouse gestational tissues during late pregnancy

ea0029p893 | Female Reproduction

Hypoxia-induced oxidative stress regulates the expressions of calcium transport channels in the duodenum, kidney and placenta of rats

ea0029p894 | Female Reproduction

Daily serum testosterone during the menstrual cycle by ID-LC–MS/MS

ea0029p895 | Female Reproduction

NT-pro-BNP levels in patients with polycystic ovarian syndrome

ea0029p896 | Female Reproduction

Differential expression and regulation of Mg2+ inorganic phosphate transport channels by hypoxia stress in human placental cells

ea0029p897 | Female Reproduction

Progesterone levels on the hCG day and outcomes IVF in women with polycystic ovary syndrome

ea0029p898 | Female Reproduction

State of care in women affected by early premature ovarian failure (ePOF) within the first two years of treatment in a center for reproductive medicine and endocrinology (RME)

ea0029p899 | Female Reproduction

Nutritional status and reproductive morbidity among women (age 15–40 years) in Dhaka city

ea0029p900 | Female Reproduction

Anthropometric indices of visceral obesity and cardiovascular risk factors in patients with polycystic ovarian syndrome

ea0029p901 | Female Reproduction

Health related behaviour and understanding of menopausal therapies among women with premature menopause

ea0029p902 | Female Reproduction

The effects of the therapy with ethinylestradiol 30 μg-drospirenone+metformin on endothelial dysfunction in the polycystic ovary syndrome

ea0029p903 | Female Reproduction

Hormonal contraception and female sexual function

ea0029p904 | Female Reproduction

Metformin in treatment of polycystic ovaries syndrome in women of birthing age

ea0029p905 | Female Reproduction

Letrozole induces metabolic and reproductive disorders in female rats: a dose response study

ea0029p906 | Female Reproduction

Increased prevalence of polycystic ovary syndrome in overweight and obese premenopausal women with nonalcoholic fatty liver disease

ea0029p907 | Female Reproduction

Association of the (TAAAA)n repeat polymorphism of SHBG gene with age at menopause in Greek postmenopausal women

ea0029p908 | Female Reproduction

Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome: according to the recently defined criteria

ea0029p909 | Female Reproduction

Most of type 2 diabetes associated loci identified in genome-wide association studies are not associated with polycystic ovary syndrome

ea0029p910 | Female Reproduction

Optimization of a uterine leiomyoma xenograft model using different immunodeficient mice and grafting procedures

ea0029p911 | Female Reproduction

The polymorphic variants K121Q of the plasma cell membrane glycoprotein and G972R of the insulin receptor substrate-1 modulate in opposite ways the clinical and biochemical profiles of women with polycystic ovary syndrome

ea0029p912 | Female Reproduction

Exposure to soy isoflavones during postnatal life disrupts structural development of reproductive organs in female mice

ea0029p913 | Female Reproduction

The kisspeptin levels in girls

ea0029p914 | Female Reproduction

Subcutaneous adipose tissue in women with polycystic ovary syndrome

ea0029p915 | Female Reproduction

Plasma anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus

ea0029p916 | Female Reproduction

The role of subclinical hypothyroidism and vitamin D deficiency in the development of menstrual disorders in women with PCOS

ea0029p917 | Female Reproduction

Treatment of androgen excess in adolescent girls: ethinylestradiol–cyproteroneacetate vs low-dose pioglitazone–flutamide–metformin

ea0029p918 | Female Reproduction

Hyperandrogenism is related to adipose tissue dysfunction as reflected by VAI in polycystic ovary syndrome patients

ea0029p919 | Female Reproduction

Effects of berberine on the clinical, metabolic and reproductive features of obese polycystic ovary syndrome women

ea0029p920 | Female Reproduction

Large-for-gestational-age and macrosomic neonates born by women with gestational diabetes mellitus diagnosed by the new IADPSG criteria: a case–control study of 301 patients and 839 controls

ea0029p921 | Female Reproduction

Factors affecting time to pregnancy: lithuanian women cohort study

ea0029p922 | Female Reproduction

Insulin and androgens but not androgen receptor CAGn polymorphysm are determinant factors for hirsutism severity in PCOS

ea0029p923 | Female Reproduction

Frequency of insulin resistance, assessed by the glucose clamp technique, in 132 PCOS women

ea0029p924 | Female Reproduction

Propranolol prevents stress induced polycystic ovary syndrome

ea0029p925 | Female Reproduction

Variants of the NR5A1 gene in a large cohort of patients with primary ovarian insufficiency

ea0029p926 | Female Reproduction

Aberrant expression of TRAIL in placenta and maternal serum in early pregancy complications

ea0029p927 | Female Reproduction

Blood cell mitochondrial DNA content and premature ovarian aging

ea0029p928 | Female Reproduction

Fetal growth parameters and outcome of pregnancies complicated with thyroid disease

ea0029p929 | Female Reproduction

Endocrine effects of the FSHB−211 promoter polymorphism in females

ea0029p930 | Female Reproduction

The prevalence of endometrial hyperplasia and endometrial cancer in Danish women with PCOS or hyperandrogenism

ea0029p931 | Female Reproduction

Conformational control of P450aromatase by lipid membrane interactions and protein associations

ea0029p932 | Female Reproduction

Metabolic characteristics in women with polycystic ovary syndrome by phenotypes based on various diagnostic criteria

ea0029p933 | Female Reproduction

Prevalence of chronic autoimmune thyroiditis in patients with polycystic ovary syndrome

ea0029p934 | Female Reproduction

Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance

ea0029p935 | Female Reproduction

Candidate pathway genetic analysis of PCOS

ea0029p936 | Female Reproduction

Sex hormones and sexual function in postmenopause

ea0029p937 | Female Reproduction

Hypoandrogenemia at women with hypogonadotropic hypogonadism

ea0029p938 | Female Reproduction

Nonalcoholic fatty liver disease in pregnant women.

ea0029p939 | Female Reproduction

AMH and INSL3 levels in ovulatory and anovulatory women with the polycystic ovary syndrome

ea0029p940 | Female Reproduction

Increased risk of glucose metabolism impairment after gestational diabetes in polycystic ovary syndrome

ea0029p941 | Female Reproduction

Effect of antiandrogens on spontaneous apoptosis in cultured porcine granulosa cells

ea0029p942 | Female Reproduction

Prenatal exposure to anti-androgen flutamide influences connexin 43 expression in the porcine fetal gonads

ea0029p943 | Female Reproduction

Long term health status of POI Patients

ea0029p944 | Female Reproduction

Neonates of women with polycystic ovary syndrome display increased oxidative stress markers and metabolic aberrations comparable to gestational diabetes offspring

ea0029p945 | Female Reproduction

Impact of dietary advanced glycation end products modifications on metabolic and hormonal profile in women with polycystic ovary syndrome

ea0029p946 | Female Reproduction

Inhibin-α gene promoter polymorphisms in patients with idiopathic premature ovarian failure

ea0029p947 | Female Reproduction

Skeletal frame size in females with polycystic ovary syndrome

ea0029p948 | Female Reproduction

Quality of life and the frequency of anxiety and depression in women with PCOS

ea0029p949 | Female Reproduction

Examination of the generation of vaginal epithelium of the new vagina formed using oxidized regenerated cellulose

ea0029p950 | Female Reproduction

Efficacy of sex hormone replacement therapy on induction of puberty in patients with Turner syndrome

ea0029p951 | Female Reproduction

Different effects of electrical and manual acupuncture stimulation on estrous cyclicity and neuroendocrine function in rats with DHT-induced polycystic ovary syndrome

ea0029p952 | Female Reproduction

The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters in women with polycystic ovary syndrome

ea0029p953 | Female Reproduction

Androgens profile in Cushing’s disease with hirsutism

ea0029p954 | Female Reproduction

Action of elevated leptin levels on steroidogenic enzymes expression in porcine small and medium size follicles collected from prepubertal and cycling pig

ea0029p955 | Female Reproduction

The role and mechanisms of action of leptin in control of ovarian functions

ea0029p956 | Female Reproduction

What is the earliest predictor of atherosclerosis in normal weight polycystic ovary syndrome; carotid intima media thickness or visceral fat ratio?

ea0029p957 | Female Reproduction

Prevalence of hyperandrogenism, polycystic ovary syndrome and metabolic syndrome in female-to-male transsexuals

ea0029p958 | Female Reproduction

Examination of the role of gynecologists in the management of patients with disorders of sex development

ea0029p959 | Female Reproduction

Polycystic ovary syndrome, hyperprolactinemia, hyperinsulinemia and congenital adrenal hyperplasia

ea0029p960 | Female Reproduction

The future of HRT

ea0029p961 | Female Reproduction

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case–control study

ea0029p962 | Female Reproduction

Impaired beta cell function in Chinese women with polycystic ovary syndrome

ea0029p963 | Female Reproduction

Epicardial adipose tissue thickness in patients with polycystic ovary syndrome

ea0029p964 | Female Reproduction

High plasma level of long pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

ea0029p965 | Female Reproduction

Sertoli cells ovarian tumor- an ovarian incidentaloma?

ea0029p966 | Female Reproduction

Clinical, hormonal and metabolic profile in overweight and obese women with polycystic ovary syndrome

ea0029p967 | Female Reproduction

Serum 17β-estradiol concentration and depression symptoms presence in climacteric women

ea0029p968 | Female Reproduction

Assessment of insulin resistance and carotid intima media thickness, cardiovascular risk factors in PCOS with normal OGTT

ea0029p969 | Female Reproduction

Relation of hyperandrogenism and metabolic derangements in women with polycystic ovary syndrome

ea0029p970 | Female Reproduction

Micronized progesterone: a beneficial new modality of treatment for Egyptian patients with hyperemesis gravidarum

ea0029p971 | Female Reproduction

Significance of obesity in the genesis of metabolic syndrome in women with polycystic ovary syndrome

ea0029p972 | Female Reproduction

Lipid accumulation product as a marker of metabolic syndrome in women with polycystic ovary syndrome

ea0029p973 | Female Reproduction

Serum 25-hydroxyvitamin D and hsCRP levels in young obese women with polycystic ovary syndrome

ea0029p974 | Female Reproduction

Association of metabolic disturbances and carotid intima-media thickness in women with polycystic ovary syndrome

ea0029p975 | Female Reproduction

Prevalence of dyslipidemia in Algerian PCOS women

ea0029p976 | Female Reproduction

Serial serum levels of vitamin D in lean and obese pregnant women

ea0029p977 | Female Reproduction

Erythrocytosis and thrombocytosis secondary to hypertestosteronemia caused by ovarian leydig cell tumor

ea0029p978 | Female Reproduction

Quality of life in patients affected by polycystic ovary syndrome

ea0029p979 | Female Reproduction

Effects of dopamine agonist administration during seasonal cyclicity in the mare

ea0029p980 | Female Reproduction

Differences in gonadal axis reaction to ketoconasole between PCOS and healthy individuals

ea0029p981 | Female Reproduction

Metabolic and hormonal parameters in lean PCOS women

ea0029p982 | Female Reproduction

Adiponectin, resistin, leptin and selected cytokines in association with insulin resistance in lean women with polycystic ovary syndrome

ea0029p983 | Female Reproduction

Solution of an old endocrinological puzzle the rise and fall of an endocrinological doctrine Dr. László Makay, DVM H-2000 Szentendre, Sztaravodai u. 42, Hungary Tel./Fax: +36 26 316 791 E-mail: [email protected]

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more